Cardiovascular risk in newly diagnosed type 2 diabetes patients in India

被引:16
|
作者
Unnikrishnan, A. G. [1 ]
Sahay, R. K. [2 ]
Phadke, Uday [3 ]
Sharma, S. K. [4 ]
Shah, Parag [5 ]
Shukla, Rishi [6 ]
Viswanathan, Vijay [7 ]
Wangnoo, S. K. [8 ]
Singhal, Santosh [9 ]
John, Mathew [10 ]
Kumar, Ajay [11 ]
Dharmalingam, Mala [12 ]
Jain, Subodh [13 ]
Shaikh, Shehla [14 ]
Verberk, Willem J. [15 ]
机构
[1] Chellaram Diabet Inst, Pune, Maharashtra, India
[2] Osmania Gen Hosp, Osmania Med Coll, Dept Endocrinol, Hyderabad, India
[3] Sahyadri Hosp, Pune, Maharashtra, India
[4] Galaxy Special Ctr, Jaipur, Rajasthan, India
[5] Gujarat Endocrine Ctr, Ahmadabad, Gujarat, India
[6] Dr Rishi Shukla Ctr Diabet & Endocrine Dis, Kanpur, Uttar Pradesh, India
[7] MV Hosp Diabetes, Chennai, Tamil Nadu, India
[8] Indraprashth Apollo Hosp, New Delhi, India
[9] Sparsh Hlth Care & CHS Apple Hosp, Gwalior, Madhya Pradesh, India
[10] Providence Endocrine & Diabet Specialty Ctr, Trivandrum, Kerala, India
[11] Diabet Care & Res Ctr, Patna, Bihar, India
[12] Bangalore Endocrinol & Ctr, Bangalore, Karnataka, India
[13] Diabet Care Ctr, Prayagraj, Uttar Pradesh, India
[14] KGN Diabet & Endocrinol Ctr, Mumbai, Maharashtra, India
[15] Maastricht Univ, CARIM Sch Cardiovasc Dis, Maastricht, Netherlands
来源
PLOS ONE | 2022年 / 17卷 / 03期
关键词
INSULIN-RESISTANCE; VASCULAR-DISEASE; METAANALYSIS; NICOTINE; MELLITUS; CHOLESTEROL; MECHANISMS; SMOKING; GOALS;
D O I
10.1371/journal.pone.0263619
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Type 2 diabetes mellitus (T2DM) worldwide continues to increase, in particular in India. Early T2DM diagnosis followed by appropriate management will result in more cardiovascular event free life years. However, knowledge of the cardiovascular profile of newly diagnosed T2DM patients is still limited. The aim of this study was to understand the extent of cardiovascular disease (CVD) risk of newly diagnosed T2DM patients in India. Methods A cross sectional observational study was conducted to evaluate clinical laboratory and socio-demographic parameters of 5,080 newly diagnosed T2DM patients (48.3 12.8 years of age; 36.7% female). In addition, we determined their cardiovascular risk according to the guidelines of the Lipid Association of India (LAI) and the criteria of the QRISK3 score. Results Of the newly T2DM diagnosed patients in India 2,007(39.5%) were classified as "High risk" and 3,073 (60.5%) were classified as "Very high risk" based on LAI criteria. On average, patients had 1.7 +/- 0.9 major atherosclerotic cardiovascular disease (ASCVD) risk factors. Low HDL-C value was the most frequent major risk (2,823; 55.6%) followed by high age (2,502; 49.3%), hypertension (2,141; 42.1%), smoking/tobacco use (1,078; 21.2%) and chronic kidney disease stage 3b or higher (568; 11.2%). In addition, 4,192 (82.5%) patients appeared to have at least one cholesterol abnormality and, if the latest LAI recommendations are applied, 96.5% (4,902) presented with lipid values above recommended targets. Based on the QRISK3 calculation Indian diabetes patients had an average CVD risk of 15.3 +/- 12.3%, (12.2 +/- 10.1 vs. 17.1 +/- 13.5 [p<0.001] for females and males, respectively). Conclusions Newly diagnosed Indian T2DM patients are at high ASCVD risk. Our data therefore support the notion that further extension of nationwide ASCVD risk identification programs and prevention strategies to reduce the occurrence of cardiovascular diseases are warranted.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Cardiovascular risk in patients with newly diagnosed type 2 diabetes mellitus
    Fuadal-Saraj
    McAteer, S
    Galvin, J
    Keelan, E
    Fitzgerald, D
    Cawood, T
    Sreenan, SK
    [J]. DIABETES, 2005, 54 : A172 - A172
  • [2] 10-Year Cardiovascular Risk in Patients With Newly Diagnosed Type 2 Diabetes Mellitus
    Gyldenkerne, Christine
    Mortensen, Martin Bodtker
    Kahlert, Johnny
    Thrane, Pernille Gro
    Olesen, Kevin Kris Warnakula
    Sorensen, Henrik Toft
    Thomsen, Reimar Wernich
    Maeng, Michael
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 82 (16) : 1583 - 1594
  • [3] The Cardiovascular Risk of Sulfonylureas on Newly Diagnosed Type II Diabetes Mellitus Patients
    Wu, Yi-ting
    Gau, Churn-Shiouh
    [J]. DRUG SAFETY, 2009, 32 (10) : 945 - 946
  • [4] Analysis of the main cardiovascular risk factors in Uygur and Han patients with newly diagnosed type 2 diabetes
    Li, Jingjing
    [J]. DIABETES-METABOLISM RESEARCH AND REVIEWS, 2018, 34
  • [5] INCREASED PREVALENCE OF CARDIOVASCULAR RISK FACTORS IN NEWLY DIAGNOSED TYPE 2 DIABETES PATIENTS - A RETROSPECTIVE STUDY
    Roman, G.
    Teodorescu, G.
    [J]. ACTA ENDOCRINOLOGICA-BUCHAREST, 2021, 17 (03)
  • [6] Prevalence of Cardiovascular Autonomic Neuropathy in a Cohort of Patients With Newly Diagnosed Type 2 Diabetes: The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS)
    Zoppini, Giacomo
    Cacciatori, Vittorio
    Raimondo, Daniele
    Gemma, Marialuisa
    Trombetta, Maddalena
    Dauriz, Marco
    Brangani, Corinna
    Pichiri, Isabella
    Negri, Carlo
    Stoico, Vincenzo
    Bergamini, Corinna
    Targher, Giovanni
    Santi, Lorenza
    Thomaseth, Karl
    Bellavere, Federico
    Bonadonna, Riccardo C.
    Bonora, Enzo
    [J]. DIABETES CARE, 2015, 38 (08) : 1487 - 1493
  • [7] Hypertensive waist as a cardiovascular risk factor in newly diagnosed Type 2 diabetes persons
    Hancu, ND
    Roman, G
    Negrean, M
    Bala, CG
    Nita, C
    [J]. DIABETOLOGIA, 2004, 47 : A419 - A419
  • [8] Vascular risk in newly diagnosed type 2 diabetes
    Trowbridge, SN
    Kerr, D
    Cavan, DA
    [J]. DIABETES, 1999, 48 : A370 - A370
  • [9] Effects of Glimepiride on metabolic parameters and cardiovascular risk factors in patients with newly diagnosed type 2 diabetes mellitus
    Xu, Dan-yan
    Zhao, Shui-Ping
    Huang, Qiu-xia
    Du, Wei
    Liu, Yu-hua
    Liu, Ling
    Xie, Xiao-mei
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2010, 88 (01) : 71 - 75
  • [10] PREDICTORS OF MORTALITY AND CARDIOVASCULAR EVENTS IN PATIENTS NEWLY DIAGNOSED WITH TYPE 2 DIABETES MELLITUS
    Hunter, T. M.
    Alatorre, C., I
    Hoogwerf, B.
    Deeg, M.
    Nelson, D.
    Jiang, D.
    Rekhter, M.
    [J]. VALUE IN HEALTH, 2016, 19 (03) : A200 - A200